TRIMU 5
| TRIMU 5 | |
|---|---|
| 200px | |
| IUPAC name | (2S)-2-amino-3-(4-hydroxyphenyl)-N-[(2R)-1-[ [2-(3-methylbutylamino)acetyl]amino]-1-oxopropan-2-yl]propanamide |
| Identifiers | |
| CAS number | |
| PubChem | |
| SMILES | CC(C)CCNCC(=O)NC(=O)C(C) NC(=O)C(CC1=CC=C(C=C1)O)N |
| Properties | |
| Molecular formula | C19H30N4O4 |
| Molar mass | 378.466 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
TRIMU 5 is a selective agonist of the mu-2 mu opioid receptor.[1]
References
- ↑ Eisenberg RM (1994). "TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis". Pharmacol. Biochem. Behav. 47 (4): 943-6. PMID 8029266.
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
